No Data
Sernova to Amend Warrants, Extend Expiry, and Cut Exercise Price
Sernova Converts $13.3M Debt to Equity Ahead of Clinical Milestone
Eledon And Sernova Collaborate To Test Tegoprubart As Safer Immunosuppressant In Sernova's Phase 1/2 Cell Pouch Trial For Type 1 Diabetes
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to Be Highlighted at Cell & Gene Meeting on the Med
Sernova Biotherapeutics Secures CAD$1M Convertible Debt Financing
Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics